H7N9 should blow over like previous flus, and when it does, those companies that got bumped or boosted amid the crisis should revert back to their prior trends. More
21 Commercial Banking Stocks to Buy Now
This week, 21 Commercial Banking stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
Proposed IRA Change Is Punishment, Not Progress
A carve-out in the Obama budget proposal for capping retirement account tax advantages is crazy. Don't punish people for trying to save for retirement. More
Should I Buy JCPenney? 2 Pros, 6 Cons
Does struggling retailer JCPenney have a shot in the dark now that CEO Ron Johnson has gotten the boot? Here are a couple pros and a lot more cons on the stock. More
Yahoo, Apple & Microsoft: Technology’s Digital Love Triangle
Yahoo and Apple are looking to take their relationship to the next level ... but Microsoft could come between them. More
Student Debt: Lots of Noise, Little Progress
Many talking heads will clamor about the looming interest rate hike for subsidized Stafford loans, but that only serves to oversimplify the much more complex issue of student debt. More
5 Biotechnology Stocks to Buy Now
Five Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More
